Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (5045)	8/6/1998 3:22:00 PM
From: JMM	Read Replies (2) \| Respond to of 6136

Bill Kirn has been a perpetual bull on this stk since I read him over 1 1/2 yrs ago. At that time his projections were for the stk to go to 70. Well........The stk is now valued like any other stk based on its earnings.....which at the current level aren't as heady as when people could project numbers based on potential. The sky was the limit then and the stk reflected those hopes. It is in reality a one drug firm until something emerges from a pipeline which dosen't have anything in the visible future to base any revenue or earning numbers for. The stk may be close to washed out in here but the real days of shooting forever higher may be over.